Key Drivers
- Positive FCF
- Thin liquidity
- High leverage
AIAI Summary
Pennant is now an acquisitive, integration‑dependent growth story where upside requires timely realization of synergies, improved AR/occupancy cash conversion and deleveraging, while thin liquidity, high intangibles and leverage leave scant room for execution or reimbursement misses.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Positive FCF
- •Thin liquidity
- •High leverage
PNTG generates solid scale and free cash flow but faces material risk from high leverage, thin liquidity, modest margins, and a premium valuation.
Price Behavior
Key Price Behavior Insights:
- •Below last month SMA
- •Support cluster
- •Resistance band
PNTG is trading ~6% below its last month average (~$33.04), showing short-term downside bias but resilience after the $30.49 dip with a possible rebound toward $34.0–$34.5 if momentum returns.
~12% peak-to-trough drop from $34.44 to $30.49 over last month indicating moderate volatility
Sentiment & News
Key News Insights:
- •Profitable 2025
- •Institutional selling
- •Investor outreach
PNTG reported profitable 2025 results (GAAP EPS $0.84; adjusted $1.18), experienced a 34% stake reduction by 8 Knots Management, and will host investor outreach at the Oppenheimer MedTech conference, signaling potential near-term scrutiny and further disclosure. #share-sale
Reported earnings support valuation but the large institutional sale could weigh on the stock until conference presentations provide clearer guidance
Similar Companies in Healthcare
Other companies in the same sector with AI ratings